However, some may take it off-label (meaning for a use the FDA has not approved) to treat bipolar disorder. Various studies ...

Explore hyposexuality in bipolar disorder, including symptoms like low libido, reduced sexual desire, and difficulty ...

Doctors sometimes use lithium to treat schizophrenia. However, it is not a primary treatment method and evidence of its ...

Discover real experiences from our bipolar community on the potential benefits and challenges of ketogenic therapy for mood ...

The U. S. Food and Drug Administration (FDA) has signed off on Cobenfy, the first revolutionary treatment for schizophrenia ...

In the Netherlands, euthanasia among psychiatric patients appears to be rising, albeit from a low base: there were 115 cases ...

One of the well known symptoms of clinical depression is episodes of pervasive sadness. But you might not know that there are ...

Four Australians have been recognised, including a researcher who’s created an equine therapy program for Aboriginal youth ...

. Increasing Prevalence: The lifetime prevalence of bipolar disorder is estimated at 1%, with a one-year prevalence of about 0.5% globally. The rise in diagnoses is attributed to greater awareness and ...

You may have heard about ketamine in the news, but did you know that the right dose of this medicine can stimulate your brain ...

RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine ...

“Among the millions of people in the U.S. suffering from the debilitating effects of depression, more than half experience an inadequate response to their current antidepressant, underscoring the ...